ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Patients “Raise A Voice” For Provenge Approval.

April 27, 2007

NCI Begins Large National Clinical Trial To Validate Biomarker For Lung Cancer

October 31, 2008

Rhoads Suggests Plan For 200 Clinical Centers

January 28, 1977

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977